Your browser doesn't support javascript.
loading
A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran.
Andersson, Ulf; Lindberg, Johan; Wang, Shunghuang; Balasubramanian, Raji; Marcusson-Ståhl, Maritha; Hannula, Mira; Zeng, Chenhui; Juhasz, Peter J; Kolmert, Johan; Bäckström, Jonas; Nord, Lars; Nilsson, Kerstin; Martin, Steve; Glinghammar, Björn; Cederbrant, Karin; Schuppe-Koistinen, Ina.
Affiliation
  • Andersson U; Safety Assessment, Molecular Toxicology, AstraZeneca R&D, Södertälje, Sweden. ulf.s.andersson@astrazeneca.com
Biomarkers ; 14(8): 572-86, 2009 Dec.
Article in En | MEDLINE | ID: mdl-19780643
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azetidines / Benzylamines / Biomarkers / Alanine Transaminase / Chemical and Drug Induced Liver Injury Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Biomarkers Journal subject: BIOQUIMICA Year: 2009 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azetidines / Benzylamines / Biomarkers / Alanine Transaminase / Chemical and Drug Induced Liver Injury Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Biomarkers Journal subject: BIOQUIMICA Year: 2009 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido